Physician
Ophthalmology
Dr. Nancy Holekamp, MD
|
|
Give Review
Nancy Holekamp works in the field of Ophthalmology. She researched medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a one of the best medicals schools. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. She received 3 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAO)". Nancy Holekamp is a published doctor. She published 48 publications, including: 'Surgical removal of extensive peripapillary choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.' Nancy Holekamp accepts Medicare payments and is registered with Medicare.gov.
Publications
- Preserve the (intraOcular) environment: the importance of maintaining normal oxygen gradients in the eye.
- Clinical Utilization of Anti-VEGF Agents and Disease Monitoring in Neovascular Age-Related Macular Degeneration.
- Racial differences in Ocular oxidative metabolism: implications for Ocular disease.
- Vitreoretinal influences on lens function and Cataract.
- Myocardial infarction and cerebrovascular accident in patients with Retinal vein occlusion.
- Oxygen distribution in the human eye: relevance to the etiology of open-angle Glaucoma after vitrectomy.
- Ischemic diabetic retinopathy may protect against nuclear sclerotic cataract.
- Oxidative damage and the prevention of age-related Cataracts.
- The vitreous gel: more than meets the eye.
- Surgical outcome of scleral buckling compared with scleral buckling with vitrectomy for treatment of macula-off Retinal detachment.
- The gel state of the vitreous and ascorbate-dependent oxygen consumption: relationship to the etiology of nuclear Cataracts.
- Intravitreal bevacizumab for choroidal neovascularization in Ocular histoplasmosis.
- Myopia and axial length contribute to vitreous liquefaction and nuclear Cataract.
- Long-term follow-up of surgical removal of extensive peripapillary choroidal neovascularization in presumed Ocular histoplasmosis syndrome.
- Comparison of methods to identify incident cataract in eyes of patients with neovascular maculopathy: SubMacular Surgery Trials Report No. 18.
- Safety of intravitreal injections in patients receiving warfarin anticoagulation.
- Safety of intravitreal injection of bevacizumab in rabbit eyes.
- Lower intraocular oxygen tension in diabetic patients: possible contribution to decreased incidence of nuclear sclerotic Cataract.
- Oxygen distribution in the rabbit eye and oxygen consumption by the lens.
- Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
- Surgical removal of peripapillary choroidal neovascularization associated with age-related Macular degeneration.
- The safety profile of long-term, high-dose intraOcular corticosteroid delivery.
- Vitrectomy surgery increases oxygen exposure to the lens: a possible mechanism for nuclear Cataract formation.
- Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.
- Surgery for subfoveal choroidal neovascularization in age-related Macular degeneration: ophthalmic findings: SST report no. 11.
- Importance of vitreous liquefaction in age-related Cataract.
- Human intraOcular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.
- Pars plana vitrectomy in eyes containing a treated posterior uveal melanoma.
- Outcome results in Macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green.
- Case-control study of Endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds.
- Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to Ocular histoplasmosis syndrome.
- Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related Macular degeneration.
- "Luggage-tag" suture fixation of partially dislocated intraOcular lenses.
- Open retinotomy after subMacular surgery.
- Management of Diabetic retinopathy.
- Ulnar neuropathy as a complication of Macular hole surgery.
- Diagnosis and management of idiopathic Macular holes.
- Surgical removal of extensive peripapillary choroidal neovascularization associated with presumed Ocular histoplasmosis syndrome.
- Treatment of pseudophakic CME.
- IntraOcular anesthetic following peribulbar anesthesia.
- Retinal pigment epithelial changes following Macular hole surgery.
- Vitrectomy for the management of recurrent Retinal detachments.
- Surgical removal of subfoveal choroidal neovascularization in presumed Ocular histoplasmosis: stability of early visual results.
- Altered thyroidal states modulate the insulin receptor characteristics of the developing rabbit brain.
- Ontogenesis of the insulin receptor in the rabbit brain.
- Insulin downregulates neonatal brain insulin receptors.
- Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic Macular edema.
Schools
Johns Hopkins University School Of Medicine
Barnes Jewish Hospital S Campus
Procedures Preformed
- Destruction of Lesion of Retina and Choroid
- Repair of Retinal Detachment or Retinal Tear
- Vitrectomy (incl. Macular Hole Repair)
Conditions Treated
- Acute Endophthalmitis
- Age-Related Macular Degeneration
- Anterior Ischemic Optic Neuropathy
- Benign Neoplasm of Eye
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAO)
Education
-
Washington University - Barnes-Jewish Hospital -
Johns Hopkins University School of Medicine
Hospital
-
St. Luke's Hospital
Drug Facts
| NPI NUMBER | 1831197557 | |
| NPPES Provider LastName | HOLEKAMP | |
| NPPES Provider FirstName | NANCY | |
| NPPES Provider ZIPCode | 630175065 | |
| NPPES Provider State | MO | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 359.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1831197557 |
| Last Name Of The Provider | HOLEKAMP |
| First Name Of The Provider | NANCY |
| View All |
Similar Doctors
|
Dr. Richard I. Goldberg, MD |
|
|
Dr. Stephen G. Slocum, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven M. Shields, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert L. Lamberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald C. Bilchik, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bruce H. Cohen, MD |
|
|
Dr. John C. Perlmutter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard C. Chu, DO |
|
|
Dr. Paul A. Hein Jr., MD |